A phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of Recombinant Human Adenovirus 5 Injection (Oncorine) in patients with malignant ascites by intraperitoneal infusion

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
This article has no abstract
Epistemonikos ID: e9c5204d42b1ef2d89aaf0c5c3ffac26ca6f985c
First added on: Apr 08, 2025